Search Results - "Howes, Oliver"

Working memory processes and the histamine-3 receptor in schizophrenia: a [¹¹C]MK-8278 PET-fMRI study.

Authors: Arumuham, Atheeshaan Shatalina, Ekaterina Nour, Matthew M. et al.

Source: Psychopharmacology. Jun2025, Vol. 242 Issue 6, p1321-1334.

Relapse in Schizophrenia: A Systematic Review of Criteria for Clinical Studies and International Consensus Guidelines to Improve Them.

Authors: Howes, Oliver D. Bukala, Bernard R. Chen, Eric Y.H. et al.

Source: American Journal of Psychiatry. Nov2025, Vol. 182 Issue 11, p969-983. 15p.

Evaluation of the impact of low activity imaging in [¹¹C]-(+)-PHNO and [¹¹C]UCB-J PET-MR scans.

Authors: Ribeiro, Daniela Hallett, William Howes, Oliver et al.

Source: EJNMMI Physics. 3/10/2026, Vol. 13 Issue 1, p1-18. 18p.

Meta-analysis and systematic review of vesicular monoamine transporter (VMAT-2) inhibitors in schizophrenia and psychosis.

Authors: Connolly, Anne Wallman, Phoebe Dzahini, Olubanke et al.

Source: Psychopharmacology. Feb2024, Vol. 241 Issue 2, p225-241.

Striatal dopamine synthesis capacity and its association with negative symptoms upon resolution of positive symptoms in first-episode schizophrenia and delusional disorder.

Authors: Wong, Stephanie M. Y. Suen, Y. N. Wong, Charlotte W. C. et al.

Source: Psychopharmacology. Jul2022, Vol. 239 Issue 7, p2133-2141.

Adenosine A2A receptor in schizophrenia: an in vivo brain PET imaging study.

Authors: Marques, Tiago Reis Natesan, Sridhar Rabiner, Eugenii A. et al.

Source: Psychopharmacology. Nov2022, Vol. 239 Issue 11, p3439-3445.

The effects of AUT00206, a novel Kv3.1/3.2 potassium channel modulator, on task-based reward system activation: a test of mechanism in schizophrenia.

Authors: Kaar, Stephen J. Angelescu, Ilinca Nour, Matthew M. et al.

Source: Psychopharmacology. Oct2022, Vol. 239 Issue 10, p3313-3323.

The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study.

Authors: Bloomfield, Michael A. P. Yamamori, Yumeya Hindocha, Chandni et al.

Source: Psychopharmacology. May2022, Vol. 239 Issue 5, p1539-1549.

Effect of the TAAR1 Partial Agonist Ralmitaront on Presynaptic Dopamine Synthesis Capacity Measured Using [ 18 F]DOPA PET in Naïve and Cocaine-Treated Mice.

Authors: Bonsall, David R. Kokkinou, Michelle Halff, Els F. et al.

Source: Molecular Imaging. 12/18/2024, Vol. 23, p1-5. 5p.

Brain volume in chronic ketamine users — relationship to sub-threshold psychotic symptoms and relevance to schizophrenia.

Authors: Chesters, Robert A. Pepper, Fiona Morgan, Celia et al.

Source: Psychopharmacology. Nov2022, Vol. 239 Issue 11, p3421-3429.

Low COVID‐19 vaccination rates in people with severe mental illness and reasons for this: An out‐patient study.

Authors: Arumuham, Atheeshaan O'Brien, Oisin Ahmad, Zain et al.

Source: Acta Psychiatrica Scandinavica. Apr2022, Vol. 145 Issue 4, p416-418. 3p. 1 Chart.

Subjects: People with mental illness, COVID-19 vaccines, Vaccination complications, Mental health services, Medical care

Editorial: Reporting guidelines for psychopharmacology.

Authors: Steckler, Thomas Curran, H. Wit, Harriet et al.

Source: Psychopharmacology. Apr2016, Vol. 233 Issue 7, p1131-1134. 4p.

Subjects: Psychopharmacology, Experimental design, Systematic reviews, Publishing, Immunoglobulins

The dark side of clarity.

Authors: Nie, Chenwei¹, chenwei.nie@outlook.com

Source: Southern Journal of Philosophy; Sep2025, Vol. 63 Issue 3, p429-443, 15p

The effects of cannabinoid 1 receptor compounds on memory: a meta-analysis and systematic review across species.

Authors: Borgan, Faith Beck, Katherine Butler, Emma et al.

Source: Psychopharmacology. Nov2019, Vol. 236 Issue 11, p3257-3270.

Altered glutamatergic response and functional connectivity in treatment resistant schizophrenia: the effect of riluzole and therapeutic implications.

Authors: Pillinger, Toby Rogdaki, Maria McCutcheon, Robert A. et al.

Source: Psychopharmacology. Jul2019, Vol. 236 Issue 7, p1985-1997.

Trends in mortality in schizophrenia and their implications.

Authors: Onwordi, Ellis Howes, Oliver

Source: Acta Psychiatrica Scandinavica. Dec2018, Vol. 138 Issue 6, p489-491. 3p.

Subjects: Diagnosis of schizophrenia, Disease risk factors, Mortality, Clozapine, Public health

An accessible, timely method for identifying medications for repurposing: hypothesis generating; testing and validation.

Authors: Lange, Maximin Gogarty, Eoin Martyn, Meredith et al.

Source: BMC Digital Health. 5/22/2025, Vol. 3 Issue 1, p1-13. 13p.

Treating Unmet Needs in Psychiatry (TUNE-UP): targeted service increases out-patient initiations of clozapine.

Authors: Khan, Zmarak Ahmad Varvari, Ioana Mancini, Valentina et al.

Source: BJPsych Open. Mar2026, Vol. 12 Issue 2, p1-7. 7p.

Użyteczność społecznego paradygmatu schizofrenii na przykładzie badania narracji użytkowników społeczności r/schizophrenia.

Alternate Title: The Utility of the Social Paradigm of Schizophrenia: A Study of User Narratives from the r/Schizophrenia Community.

Authors: Szałkowski, Paweł¹ szalkowski@doktorant.umk.pl

Source: Przegląd Socjologii Jakościowej. 2/28/2026, Vol. 22 Issue 1, p48-63. 16p.

Tobacco smoking and dopaminergic function in humans: a meta-analysis of molecular imaging studies.

Authors: Ashok, Abhishekh H. Mizuno, Yuya Howes, Oliver D.

Source: Psychopharmacology. Apr2019, Vol. 236 Issue 4, p1119-1129.